CODING Q&A
Audit Your Practice—Before the Feds Do It
Color Me Green, White, and Blue: Chromovitrectomy in Surgery
An overview of vital dyes for vitreoretinal surgery
Diabetic Retinopathy: Halting and Reversing Progression
The first of three parts
Emerging Treatments for Achromatopsia
A rare inherited cause of vision loss with clinical evaluation of gene therapies under way
First-in Class Peptide Therapy Shows 12-week Durability in DME
Equivalence to Avastin achieved with half the injections.
Ophthotech AMD Combo Fails in Phase 3
No significant benefit over Lucentis monotherapy
Geographic Atrophy Now in Researchers' Sights
Many try varied approaches to confront this unmet need.
By Jerry Helzner, contributing editor
Innovation in Retina
David N. Zacks, MD, PhD
NEW PRODUCT APPLICATIONS
Digital Visualization System Enhances Vitreoretinal Surgeries
By Karen Appold, contributing writer
SD-OCT in the Assessment of CSC
The evaluation of choroidal thickness and features in CSC.
SUBSPECIALTY NEWS
By Jerry Helzner, contributing editor
Telemedicine for Diabetic Retinopathy
Current strategies, future directions, and the role of the retinal physician
The Looming Unmet Need in Diabetic Eye Care
Part 1: A growing epidemic necessitates new approaches in therapy.
UPFRONT
Intel Inside
The Importance of Early Detection of Wet AMD
Evidence indicates early detection leads to better vision outcomes
The Science Behind the ForeseeHome AMD Monitoring Program
Preferential hyperacuity perimetry enables early detection of wet AMD
The ForeseeHome AMD Monitoring Program for Our Patients
Why and how we use this groundbreaking technology